AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (July 29, 2005). doi:10.1152/ajpheart.00590.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/H2484    most recent
00590.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamura, K.
Right arrow Articles by Murphy, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamura, K.
Right arrow Articles by Murphy, E.
Submitted on June 3, 2005
Accepted on July 23, 2005

Protein Kinase C and Preconditioning: The Role of the Sarcoplasmic Reticulum

Ken Yamamura1, Charles Steenbergen2, and Elizabeth Murphy1*

1 Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, USA
2 Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA

* To whom correspondence should be addressed. E-mail: murphy1{at}niehs.nih.gov.

Activation of protein kinase C (PKC) is cardioprotective, but the mechanism(s) by which PKC mediates protection is not fully understood. As PKC has been well documented to modulate sarcoplasmic reticulum (SR) Ca2+, and since altered SR Ca2+ handling during ischemia is involved in cardioprotection, we examined the role of PKC mediated alterations of SR Ca2+ in cardioprotection. Using isolated adult rat ventricular myocytes we found that addition of 1,2-dioctanoyl-sn-glycerol (DOG), to activate PKC under conditions that reduced myocyte death following simulated ischemia and reperfusion, also reduced SR Ca2+. Cell death was 57.9 ± 2.9 % in untreated vs. 47.3 ± 1.8 % in DOG treated myocytes (P<0.05). We examined the effect of DOG on SR Ca2+ using fura-2 fluorescence to monitor calcium transients and caffeine-releasable SR Ca2+. Caffeine-releasable SR Ca2+ was significantly reduced (by ~65%) after 10 min of DOG treatment compared to untreated myocytes (P<0.05). We examined the mechanism by which PKC alters SR Ca2+ and present the novel finding that DOG treatment reduced the phosphorylation of phospholamban (PLB) at Ser16. This effect is mediated by PKC-{epsilon}, since a PKC-{epsilon} selective inhibitory peptide blocked the DOG mediated decrease in phosphorylation of PLB and abolished the DOG induced reduction in caffeine-releasable SR Ca2+. Using immunoprecipitation, we further demonstrated that DOG increased the association between protein phosphatase-1 (PP-1) and PLB. These data suggest that activated PKC-{epsilon} reduces SR Ca2+ content through PLB dephosphorylation, and that reduced SR Ca2+ may be important in cardioprotection.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Wang, J.-F. Du, F. Wu, and H.-C. Wang
Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2540 - H2546.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. L. Moens, H. C. Champion, M. J. Claeys, B. Tavazzi, P. M. Kaminski, M. S. Wolin, D. J. Borgonjon, L. Van Nassauw, A. Haile, M. Zviman, et al.
High-Dose Folic Acid Pretreatment Blunts Cardiac Dysfunction During Ischemia Coupled to Maintenance of High-Energy Phosphates and Reduces Postreperfusion Injury
Circulation, April 8, 2008; 117(14): 1810 - 1819.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. C. Rodrigo and N. J. Samani
Ischemic preconditioning of the whole heart confers protection on subsequently isolated ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H524 - H531.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Jahangir, S. Sagar, and A. Terzic
Aging and cardioprotection
J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Shiva, Z. Huang, R. Grubina, J. Sun, L. A. Ringwood, P. H. MacArthur, X. Xu, E. Murphy, V. M. Darley-Usmar, and M. T. Gladwin
Deoxymyoglobin Is a Nitrite Reductase That Generates Nitric Oxide and Regulates Mitochondrial Respiration
Circ. Res., March 16, 2007; 100(5): 654 - 661.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.